<DOC>
	<DOCNO>NCT02392286</DOCNO>
	<brief_summary>Prospective randomize comparative effectiveness trial design compare fix dose weight-based dosing corticosteroid patient Crohn 's disease flare .</brief_summary>
	<brief_title>Corticosteroid Dosage Crohn 's Disease Flare</brief_title>
	<detailed_description>- Determine weight-based corticosteroid ( 1mg/kg daily ) induces remission great rate fix corticosteroid dosage . - Determine weight-based corticosteroid associate great rate adverse event fix corticosteroid dosage .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Age â‰¥ 18 Established diagnosis Crohn 's disease Diagnosis Crohn 's flare Decision treat gastroenterologist start corticosteroid therapy Patients corticosteroid therapy contraindicate : immunocompromised ( active cancer chemotherapy radiation treatment ) , severe liver disease ( decompensated cirrhosis , active alcoholic hepatitis ) , endstage renal disease dialysis , AIDS AIDSdefining illness ; myocardial infarction within past year ; NYHA Class 4 heart failure Patients systemic corticosteroid therapy currently within past 8 week Patients stable dos immunomodulators biologics least 8 week Infectious colitis ( e.g. , C. difficile , CMV , HSV ) Systemic infection ( bacteremia , fungal infection ) Fulminant Crohn 's disease Patients require imminent surgery Abscess Pregnancy Weight &lt; 35 kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Corticosteroid</keyword>
</DOC>